Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,608 | 30,226 | 12,118 | 14,542 | 21,858 |
| Marketable Securities | 39,910 | 49,773 | 40,905 | 50,785 | 65,126 |
| Receivables | 1,722 | 1,186 | 2,064 | 4,896 | 2,158 |
| TOTAL | $64,777 | $85,552 | $58,437 | $73,862 | $92,580 |
| Non-Current Assets | |||||
| PPE Net | 76,041 | 78,192 | 80,351 | 82,174 | 83,775 |
| Intangibles | 25,798 | 25,798 | 25,798 | 25,838 | 26,138 |
| Other Non-Current Assets | 752 | 724 | 762 | 797 | 808 |
| TOTAL | $102,591 | $104,714 | $106,911 | $108,809 | $110,721 |
| Total Assets | $167,368 | $190,266 | $165,348 | $182,671 | $203,301 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 826 | 816 | 4,800 | 4,783 | 4,767 |
| Accounts payable and accrued liabilities | 4,366 | 6,513 | 4,269 | 4,326 | 3,589 |
| Accrued Expenses | 6,772 | 7,325 | 9,525 | 8,054 | 6,857 |
| TOTAL | $43,162 | $45,966 | $48,216 | $54,491 | $55,487 |
| Non-Current Liabilities | |||||
| Long Term Debt | 31,156 | 31,372 | 31,584 | 31,785 | 31,982 |
| Deferred Revenues | 31,198 | 31,312 | 29,622 | 37,328 | 40,274 |
| Other Non-Current Liabilities | 744 | 739 | 735 | 730 | 725 |
| TOTAL | $55,202 | $58,799 | $62,482 | $66,325 | $70,882 |
| Total Liabilities | $98,364 | $104,765 | $110,698 | $120,816 | $126,369 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,191 | 11,144 | 10,900 | 9,240 | 9,235 |
| Common Shares | 78 | 78 | 66 | 65 | 65 |
| Retained earnings | -370,656 | -351,741 | -337,918 | -325,163 | -308,261 |
| Other shareholders' equity | -7 | -16 | -4 | -42 | -52 |
| TOTAL | $69,004 | $85,501 | $54,650 | $61,855 | $76,932 |
| Total Liabilities And Equity | $167,368 | $190,266 | $165,348 | $182,671 | $203,301 |